Research | Are pharma companies addressing sexual and reproductive health access barriers for women and girls?
Are pharma companies addressing sexual and reproductive health access barriers for women and girls?

Are pharma companies addressing sexual and reproductive health access barriers for women and girls?

12 February 2022

This report examines the role of pharmaceutical companies in addressing access barriers hindering women and girls’ sexual and reproductive health and rights (SRHR) globally. It assesses their research on new SRHR medicines and products, pricing strategies, company capacity building efforts, and inclusive business models.

 

Please login or join for free to read more.